1Raghu G, Collard HR, Egan J J, et al. An official ATS/ERS/JRS/ ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med, 2011, 183(6): 788-824.
3Jin S, Wang G, He B, et al. Gallium-67 scanning for detection of alveolitis in idiopathic pulmonary fibrosis and sarcoidosis. Chin Med J (Engl), 1996, 109(7): 519-521.
4Mura M, Belmonte G, Fanti S, et al. Inflammatory activity is still present in the advanced stages of idiopathic pulmonary fibrosis. Respirology, 2005, 10(5): 609-614.
6Hofland L J, Lamberts SW, van Hagen PM, et al. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [11:In- DTPA-D-Phel]octreotide in somatostatin receptor-positive organs. J Nucl Med, 2003, 44(8): 1315-1321.
7Lebtahi R, Moreau S, Marchand-Adam S, et al. Increased uptake of Htln-octreotide in idiopathic pulmonary fibrosis. J Nucl Med, 2006, 47(8): 1281-1287.
8Pasquali D, Yassallo P, Esposito D, et al. Somatostatin receptor gene expression and inhibitory effects of octreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy. J Mol Endocrinol, 2000, 25(1): 63-71.
9Yamada S,Kubota K,Kubota R,et al.High accumulation of F-18 Fluorodeoxyglucose in turpentine-induced inflammatory tissue[J].J Nucl Med,1995,36:1301-1306.
10Basu S,Chryssikos T,Moghadam-Kia S,et al.Positron emission tomography as diagnostic tool in infection:present role and future possibilities[J].Semin Nucl Med,2009,39:36-51.